MARK COHOON: Open Payments
NPI 1497754089 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 15 payments from 4 companies in 2025. Trend: 2023 $14 · 2024 $484 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 11 | $256 |
| ABBVIE INC. | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: Yeztugo, MAVYRET, ABILIFY ASIMTUFII, BREZTRI.
Industry payments across CA — which companies pay providers there.
